Skip to main content

Poliomyelitis Vaccine - Novel Oral (nOPV) Type 2 (Biological E. bulk)

Product overview

Vaccine type
Polio Vaccine - Novel Oral (nOPV) Type 2
Commercial Name
Poliomyelitis Vaccine - Novel Oral (nOPV) Type 2 (Biological E. bulk)
Manufacturer
Biological E. Limited
Manufacturer Country
India
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
50
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
Storage Temperature
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton box containing 10 vials (500 doses). Dimensions: 11x4.5x4.7 cm.
Tertiary Packaging
Carton box containing 720 vials (36000 doses). Dimensions: 66x53x43 cm
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
0.46 cm3/dose (in secondary packaging)